Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

How AI Can Accelerate Clinical Trial And Registry Builds
AI tools speed study design — from protocol creation to validation and analysis — by automating complex tasks and generating intelligent data while preserving control, accuracy, and flexibility.
No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure
This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.
Sustaining Participation In A 20-Year Alzheimer's Family Study
Learn how home-based visits can reduce burden, improve retention, and support long-term follow-up in complex clinical studies requiring years of continuous participation.
How To Make Your Clinical Trial Protocol More IRT/RTSM Friendly?
Simplifying and standardizing protocol elements strengthens RTSM builds by creating clear, repeatable structures that cut risk and boost reliability across the study lifecycle.

Learning About The Sensors In myMedidata
9/16/2025

Learn how sensor data and advanced analytics can transform clinical research and enable your study to overcome data challenges, improving patient care.
FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need To Know
8/24/2026

FDA's July 2026 final guidance on psychedelic drug clinical investigations sets expectations for sponsors developing psilocybin, LSD, and MDMA therapies. Learn what it means for your program.
Improving Clinical Research Efficiency And Access For Underserved Populations
3/26/2026

Modernizing data workflows removes geographic barriers to clinical trials, ensuring rural patients access innovative care while reducing administrative burdens on dedicated research staff.
Receptor Occupancy In The Era Of Multispecific Therapeutics
8/21/2026

Receptor occupancy studies face new challenges as multispecific therapeutics introduce complex target engagement, receptor trafficking, cellular interactions, and assay interpretation considerations.
The Triple Effect Of Community-Based Clinical Trials
6/24/2026

Taking trials into local communities improves access, boosts enrollment, reduces dropouts, and yields more representative data, speeding timelines and strengthening study quality.

Are You Preparing For First-In-Human Clinical Trials?

Reach critical first-in-human milestones faster with experienced teams, rapid study start-up, and real-time data that reduce complexity, inform decisions, and de-risk development.
Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility

Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
Advancing Lung Cancer Trials With Precision

Learn how specialized clinical expertise and global site networks accelerate complex trials. Streamline recruitment and advance novel therapies with proven operational solutions.
The Starting Point For Trial Transparency

Clinical trial sponsors can make results easier to find, understand, and share. Examine how participants stay informed while reducing manual distribution, tracking, and multilingual access challenges.
Accelerate Approval Of Novel Therapies

Learn how to make critical, data-driven decisions throughout the product development lifecycle and increase new therapies' probability of success.